Thermo Fisher is acquiring Solventum’s Purification & Filtration business for $4.1 billion to dominate biologics ...

Waters Corporation announces a $17.5 billion acquisition of Becton Dickinson's bioscience unit, expanding its reach in ...

News archive including articles on Fund Managers, Fund Selection, Asset Allocation, Absolute Return, Offshore Investments, Tax Shelters, Insurance bonds. RLAM's Mike Fox: Sustainability is ...

What is the flow cytometry market?Flow cytometry is a technique employed in laboratories to analyze the physical and chemical ...

Waters plans to combine with the Biosciences & Diagnostic Solutions business of BD (Becton, Dickinson & Co.), the companies said, in a $17.5 billion deal that would be the year’s largest within life ...

The Bedford Citizen would like to extend its thanks to our incredibly generous donors. Because of your support, The Citizen’s ...

NEW YORK (Reuters) -Prominent healthcare entrepreneur Ron Zwanziger approached medical device maker OraSure Technologies with a takeover offer, three people familiar with the matter said, in what ...

Precision for Medicine, a biomarker-driven clinical research and development company, recently unveiled its Big Five Fatigue creative campaign. Anchored by a dedicated webpage, the campaign details ...

The BD business will be spun off and merged with a Waters subsidiary. Waters shares were down about 11% in early trading Monday on the news.

NEW YORK – QuidelOrtho announced Monday an integration deal making fecal biomarker testing from Bühlmann Laboratories available on QuidelOrtho's Vitros system. The Bühlmann fecal tests detect ...

BD (NYSE: BDX) and Waters announced an agreement to create a new life science and diagnostics leader through a business ...

Thermo Fisher has recently earned a Buy rating from Wells Fargo with a $570 target, citing its strong healthcare position.